{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:13:25Z","timestamp":1791807205117,"version":"4.3.4"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Background:Candida auris (now Candidozyma auris) is an emerging pathogen that causes nosocomial candidemia, particularly in intensive care unit (ICU) settings. Its high resistance rates, prolonged environmental persistence, and outbreak potential underscore the need for robust comparative studies with non-auris Candida species (NACS). Methods: In this retrospective, case\u2013control study, adult ICU patients with candidemia were enrolled between April 2022 and October 2024. Clinical data, risk factors, and mortality at 14, 30, and 90 days were compared between the C. auris and NACS groups. Univariate and multivariate logistic regression analyses were performed to identify mortality-associated factors. Results: Of the 182 patients analyzed, candidemia due to C. auris was identified in 33 (18.1%) cases, while 149 (81.9%) cases involved NACS. Fluconazole resistance (p &lt; 0.001), prior antifungal exposure (p = 0.003), urinary catheter use (p = 0.040), and the length of ICU stay before the onset of candidemia (p &lt; 0.001) were significantly higher in the C. auris cases. However, mortality rates at 14, 30, and 90 days were similar between the groups (p = 0.331, 0.108, and 0.273, respectively). The Sequential Organ Failure Assessment score was the only consistent independent predictor of mortality at all time points. In the NACS cases, the Pitt Bacteremia Score and sepsis also predicted 30- and 90-day mortality. While late recurrence was more frequent in the cases of C. auris, early recurrence and other risk factors were similar between the groups. Conclusions:C. auris candidemia was associated with higher fluconazole resistance, prior antifungal use, longer ICU stay, more frequent urinary catheterization, and later recurrence than the NACS cases. However, the mortality rates at 14, 30, and 90 days were comparable. Outcomes were primarily influenced by illness severity rather than the infecting Candida species, highlighting the importance of timely therapy, stewardship, and infection control.<\/jats:p>","DOI":"10.3390\/jof11080552","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:19:22Z","timestamp":1753370362000},"page":"552","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Candida auris vs. Non-Candida auris Candidemia in Critically Ill Patients: Clinical Outcomes, Risk Factors, and Mortality"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-7716","authenticated-orcid":false,"given":"Ezgi","family":"G\u00fclten","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-8848","authenticated-orcid":false,"given":"G\u00fcle","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-2398","authenticated-orcid":false,"given":"Elif Mukime","family":"Sar\u0131cao\u011flu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-9148","authenticated-orcid":false,"given":"\u0130rem","family":"Akdemir","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-4552","authenticated-orcid":false,"given":"Afife Zeynep","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-1131","authenticated-orcid":false,"given":"Elif Hilal","family":"Saldere","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-8439","authenticated-orcid":false,"given":"F\u00fcgen","family":"Y\u00f6r\u00fck","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106229","DOI":"10.1016\/j.jinf.2024.106229","article-title":"Attributable mortality of candidemia\u2014Results from the ECMM Candida III multinational European Observational Cohort Study","volume":"89","author":"Cornely","year":"2024","journal-title":"J. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-018-5363-x","article-title":"What\u2019s new on emerging resistant Candida species","volume":"45","author":"Cortegiani","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"de Melo, C.C., de Oliveira, H.L.N.L., Souza, B.R., Moura, C.V.R., Oliveira, R., Bastos, R.W., Kemmerich, K.K., de Almeida-J\u00fanior, J.N., Colombo, A.L., and Spruijtenburg, B. (2025). Clade Distinction and Tracking of Clonal Spread by Fourier-Transform Infrared Spectroscopy in Multicenter Candida (Candidozyma) auris Outbreak. Mycoses, 68.","DOI":"10.1111\/myc.70085"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"De Gaetano, S., Midiri, A., Mancuso, G., Avola, M.G., and Biondo, C. (2024). Candida auris Outbreaks: Current Status and Future Perspectives. Microorganisms, 12.","DOI":"10.3390\/microorganisms12050927"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2017.08.017","article-title":"Candida auris: An emerging multidrug-resistant pathogen","volume":"63","author":"Sears","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis","volume":"161","author":"Schlattmann","year":"2022","journal-title":"Chest"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11046-020-00478-1","article-title":"Case-Case Comparison of Candida auris Versus Other Candida Species Bloodstream Infections: Results of an Outbreak Investigation in Colombia","volume":"185","author":"Caceres","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Alvarez-Moreno, C.A., Morales-L\u00f3pez, S., Rodriguez, G.J., Rodriguez, J.Y., Robert, E., Picot, C., Ceballos-Garzon, A., Parra-Giraldo, C.M., and Le Pape, P. (2023). The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?. J. Fungi, 9.","DOI":"10.3390\/jof9040430"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Phillips","year":"2016","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lai, M.Y., Hsu, J.F., Chu, S.M., Wu, I.H., Huang, H.R., Chiang, M.C., Fu, R.H., and Tsai, M.H. (2019). Risk Factors and Outcomes of Recurrent Candidemia in Children: Relapse or Re-Infection?. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010099"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11046-024-00871-0","article-title":"Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV","volume":"189","author":"Wolfgruber","year":"2024","journal-title":"Mycopathologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"dlaf078","DOI":"10.1093\/jacamr\/dlaf078","article-title":"Pitt candidaemia score as an assessment tool for mortality in patients with candidaemia caused by Candida tropicalis and other Candida species: A multicentre study conducted in Japan","volume":"7","author":"Ueda","year":"2025","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vazquez, J.A., Whitaker, L., and Zubovskaia, A. (2025). Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?. J. Fungi, 11.","DOI":"10.3390\/jof11040258"},{"key":"ref_16","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2025, July 16). EUCAST Definitive Document E.Def 7.4: Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Yeasts, Revision 2023. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/EUCAST_E.Def_7.4_Yeast_definitive_revised_2023.pdf."},{"key":"ref_17","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2025, May 01). Breakpoint Tables for Interpretation of MICs for Antifungal Agents, version 11.0. Available online: http:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals."},{"key":"ref_18","unstructured":"Centers for Disease Control and Prevention (2025, May 01). Antifungal Susceptibility Testing for Candida auris, Available online: https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/antifungal-susceptibility-testing.html."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive candidiasis in critical care: Challenges and future directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00134-017-5043-2","article-title":"Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)","volume":"44","author":"Vincent","year":"2018","journal-title":"Intensive Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pandya, N., Cag, Y., Pandak, N., Pekok, A.U., Poojary, A., Ayoade, F., Fasciana, T., Giammanco, A., Caskurlu, H., and Rajani, D.P. (2021). International Multicentre Study of Candida auris Infections. J. Fungi, 7.","DOI":"10.3390\/jof7100878"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sayeed, M.A., Farooqi, J., Jabeen, K., Awan, S., and Mahmood, S.F. (2019). Clinical spectrum and factors impacting outcome of Candida auris: A single center study from Pakistan. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3999-y"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/ciae411","article-title":"Factors Associated with Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study","volume":"79","author":"Jimenez","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Osei Sekyere, J. (2018). Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen, 7, Erratum in Microbiologyopen 2019, 8, e00901.","DOI":"10.1002\/mbo3.901"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ahmad, S., and Alfouzan, W. (2021). Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040807"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cid\/ciz535","article-title":"Resilience of the Pitt Bacteremia Score: 3 Decades and Counting","volume":"70","author":"Baddour","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/myc.13380","article-title":"Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven-year retrospective study conducted in Japan","volume":"64","author":"Miyazaki","year":"2021","journal-title":"Mycoses"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5578\/flora.20229809","article-title":"Candidemia in older adults: What are the risk factors for mortality?","volume":"27","author":"Karahan","year":"2022","journal-title":"FLORA"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sharifi, M., Badiee, P., Abastabar, M., Morovati, H., Haghani, I., Noorbakhsh, M., and Mohammadi, R. (2023). A 3-year study of Candida infections among patients with malignancy: Etiologic agents and antifungal susceptibility profile. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1152552"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Castanheira, M., Deshpande, L.M., Rhomberg, P.R., and Carvalhaes, C.G. (2024). Recent increase in Candida auris frequency in the SENTRY surveillance program: Antifungal activity and genotypic characterization. Antimicrob. Agents Chemother., 68.","DOI":"10.1128\/aac.00570-24"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"myae086","DOI":"10.1093\/mmy\/myae086","article-title":"Candida auris: Understanding the dynamics of C. auris infection versus colonization","volume":"62","author":"Park","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cristina, M.L., Spagnolo, A.M., Sartini, M., Carbone, A., Oliva, M., Schinca, E., Boni, S., and Pontali, E. (2023). An Overview on Candida auris in Healthcare Settings. J. Fungi, 9.","DOI":"10.3390\/jof9090913"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1436","DOI":"10.1093\/cid\/ciac735","article-title":"Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study","volume":"76","author":"Simon","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40121-022-00625-9","article-title":"Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors","volume":"11","author":"Briano","year":"2022","journal-title":"Infect. Dis. Ther."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/8\/552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:40Z","timestamp":1760033740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/8\/552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jof11080552"],"URL":"https:\/\/doi.org\/10.3390\/jof11080552","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}